Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
On-target, off-tumor oral toxicities of talquetamab in heavily pretreated multiple myeloma.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 02, 2025
Operationalizing Access for Chimeric Antigen Receptor T cell Therapies: A Cross-functional Perspective.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: June 23, 2025
Novel Therapies in Primary Central Nervous System Lymphoma.
Journal: Clinical pharmacology : advances and applications
Published: October 19, 2024
Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers.
Journal: Frontiers in immunology
Published: April 03, 2024
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Journal: Science advances
Published: September 22, 2023
Understanding pharmaceutical exposure and the potential for effects in marine biota: A survey of bonefish (Albula vulpes) across the Caribbean Basin.
Journal: Chemosphere
Published: September 22, 2023
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.
Journal: Transplantation and cellular therapy
Published: July 12, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
Journal: Journal for immunotherapy of cancer
Published: April 06, 2022
Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: March 25, 2021
Last Updated: 09/26/2026